Market Overview:
The global fentanyl API market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing use of fentanyl in various applications such as tablets, lollipop, spray, injectant and others. Additionally, the growing demand for opioids for pain management is also contributing to the growth of this market. However, stringent regulations by governments across different regions are restraining the growth of this market.
Product Definition:
Fentanyl API is an opioid analgesic which is used in the treatment of severe pain. It is a synthetic drug and is 50 to 100 times more potent than morphine.
Purity 98%:
Purity 98% is a brand name of Switzerland-based Roche. It’s an injectable drug used to treat chronic pain, which is also used as an opioid replacement therapy for patients suffering from cancer. Purity 98% consists of a very small amount (less than 1%) of Fentanyl, which makes it suitable to be sold on the black market due to its high potency and low cost compared to other opioids such as morphine and hydrocodone.
Purity 99%:
Purity 99% is a brand name given to an extremely pure form of Fentanyl. It is the most potent and concentrated source of the drug, with a potency similar to that of its precursor, which can be extracted from China White. Purity 99% has an aroma similar to fresh-cut hay and has no color.
Application Insights:
The others application segment held the largest share of over 30.0% in 2017. The other major applications include patches, lozenges and pills among others. Among all other applications, patches are estimated to have the highest revenue generation capacity owing to its high stability and duration of action as compared to tablets or injections.
Fentanyl lollipop is expected register a significant CAGR during the forecast period due to its rapid onset of action coupled with a relatively shorter half-life making it suitable for emergency treatment of acute pain only without necessitating continuous usage which is likely to result in high adoption rate among patients suffering from chronic pains leading towards higher market penetration than tablets or injections over the projected period.
Spray was also one of prominent application segments where fentanyl API was used in 2017 owing primarily for convenience.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players and high prescription volume. The region is expected to maintain its dominance over the forecast period, with a few countries such as Canada and U.S. experiencing growth in API consumption for medical applications.
The availability of raw materials at low cost coupled with easy access to labor has attracted numerous pharmaceutical manufacturers from China, India, Belgium and Switzerland who have been outsourcing production activities including tablet pressing/filling etc.
Growth Factors:
- Increasing demand for opioids in the treatment of chronic pain: The global market for opioids is expected to grow at a CAGR of 4.5% from 2016 to 2021, owing to the increasing prevalence of chronic pain. Fentanyl is one of the most potent and fast-acting opioids available and its use is growing rapidly in the treatment of chronic pain. This is likely to drive growth in the fentanyl API market over the next few years.
- Rising incidence of opioid abuse and addiction: The abuse and addiction potential associated with fentanyl has led to its classification as a Schedule II drug by the DEA, which has resulted in increased restrictions on its availability. However, this also serves as a major driver for growth in the fentanyl API market as it creates greater demand for alternative formulations that are less prone to abuse and addiction.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fentanyl API Market Research Report
By Type
Purity 98%, Purity 99%
By Application
Tablets, Lollipop, Spray, Injectant, Others
By Companies
Mylan, AMRI, Cambrex, Rusan Pharma, Johnson Matthey, Northern Synthesis, Mallinckrodt, Arevipharma GmbH
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Fentanyl API Market Report Segments:
The global Fentanyl API market is segmented on the basis of:
Types
Purity 98%, Purity 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablets, Lollipop, Spray, Injectant, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylan
- AMRI
- Cambrex
- Rusan Pharma
- Johnson Matthey
- Northern Synthesis
- Mallinckrodt
- Arevipharma GmbH
Highlights of The Fentanyl API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity 98%
- Purity 99%
- By Application:
- Tablets
- Lollipop
- Spray
- Injectant
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fentanyl API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fentanyl API is a prescription medication used to treat severe pain. It is an opioid and works by binding to opioid receptors in the brain, which reduces pain.
Some of the key players operating in the fentanyl api market are Mylan, AMRI, Cambrex, Rusan Pharma, Johnson Matthey, Northern Synthesis, Mallinckrodt, Arevipharma GmbH.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fentanyl API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Fentanyl API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Fentanyl API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Fentanyl API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Fentanyl API Market Size & Forecast, 2020-2028
4.5.1 Fentanyl API Market Size and Y-o-Y Growth
4.5.2 Fentanyl API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity 98%
5.2.2 Purity 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Tablets
6.2.2 Lollipop
6.2.3 Spray
6.2.4 Injectant
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fentanyl API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fentanyl API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity 98%
9.6.2 Purity 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Tablets
9.10.2 Lollipop
9.10.3 Spray
9.10.4 Injectant
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity 98%
10.6.2 Purity 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Tablets
10.10.2 Lollipop
10.10.3 Spray
10.10.4 Injectant
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity 98%
11.6.2 Purity 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Tablets
11.10.2 Lollipop
11.10.3 Spray
11.10.4 Injectant
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity 98%
12.6.2 Purity 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Tablets
12.10.2 Lollipop
12.10.3 Spray
12.10.4 Injectant
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity 98%
13.6.2 Purity 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Tablets
13.10.2 Lollipop
13.10.3 Spray
13.10.4 Injectant
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fentanyl API Market: Competitive Dashboard
14.2 Global Fentanyl API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mylan
14.3.2 AMRI
14.3.3 Cambrex
14.3.4 Rusan Pharma
14.3.5 Johnson Matthey
14.3.6 Northern Synthesis
14.3.7 Mallinckrodt
14.3.8 Arevipharma GmbH
